Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides RNA cell therapies for the treatment of autoimmune diseases. The company is headquartered in Gaithersburg, MD.
The current price of RNAC is 0.6500 USD — it has decreased by 1.57% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cartesian Therapeutics, Inc. stocks are traded under the ticker RNAC.
Cartesian Therapeutics, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Cartesian Therapeutics, Inc. has a max estimate of 2.0000 USD and a min estimate of 2.0000 USD.
Like other stocks, RNAC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cartesian Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
RNAC reached its all-time high on Nov 28, 2016 with the price of 27.9995 USD, and its all-time low was 0.5000 USD and was reached on Mar 14, 2024. See other stocks reaching their highest and lowest prices.
As of Mar 29, 2024, the company has 64.00 employees. See our rating of the largest employees — is Cartesian Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cartesian Therapeutics, Inc. EBITDA is −56.54 M USD, and current EBITDA margin is 14.96%. See more stats in Cartesian Therapeutics, Inc. financial statements.